Advanced glycation end-products affect the cytoskeletal structure of rat glomerular endothelial cells via the Ras-related C3 botulinum toxin substrate 1 signaling pathway

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4321-4326

  Lan, Lei ^a,b   Han, Yongsheng ^b   Ren, Wei ^b   Jiang, Jielong ^b   Wang, Peng ^b   Hu, Zhao ^a  

^a SHANDONG UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Cortical actin binding protein; Cytoskeletal actin; Glomerular endothelial cells; Ras related C3 botulinum toxin substrate 1 signaling pathway

Indexed keywords

BAFILOMYCIN A1; BETA ACTIN; CLATHRIN; CYTOCHALASIN D; GREEN FLUORESCENT PROTEIN; INDOMETACIN; MESSENGER RNA; ACTIN; ADVANCED GLYCATION END PRODUCT; CONTACTIN; RAC1 PROTEIN;

ACTIN POLYMERIZATION; ARTICLE; CANCER CELL LINE; CARCINOGENESIS; CELL COMMUNICATION; CELL FUNCTION; CELL ISOLATION; CELL TRANSFER; CYTOPLASM; ENDOCYTOSIS; EXOSOME; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTERNALIZATION; INTRACELLULAR TRANSPORT; LOVO CELL LINE; MULTIORGAN TUMORIGENESIS; PROTEIN FUNCTION; PROTEIN TRANSPORT; STABLE EXPRESSION; TUMOR MICROENVIRONMENT; TUMOR MODEL; AGONISTS; ANIMAL; CYTOSKELETON; DRUG EFFECTS; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLOMERULUS; MALE; METABOLISM; PERMEABILITY; RAT; SIGNAL TRANSDUCTION;

RATTUS;

ACTINS; ANIMALS; CONTACTINS; CYTOSKELETON; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY GLOMERULUS; MALE; PERMEABILITY; RAC1 GTP-BINDING PROTEIN; RATS; SIGNAL TRANSDUCTION;

EID: 84924705831     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3317     Document Type: Article

References (51)

1. Ying WZ, Lin SY and Qiu CL: Study of permeability of the glomerular capillary wall in human membranous nephropathy. Zhonghua Nei Ke Za Zhi 25: 227-231, 254, 1986 (In Chinese).
2. Satchell SC and Braet F: Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 296: F947-F956, 2009.
3. Myers BD: Pathophysiology of proteinuria in diabetic glomerular disease. J Hypertens Suppl 8: S41-S46, 1990.
4. Remuzzi G and Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990.
5. Schnoor M, Lai FP, Zarbock A, et al: Cortactin deficiency is associated with reduced neutrophil recruitment but increased vascular permeability in vivo. J Exp Med 208: 1721-1735, 2011.
6. Romero IA, Radewicz K, Jubin E, Michel CC, Greenwood J, Couraud PO and Adamson P: Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett 344: 112-116, 2003.
7. Dudek SM and Garcia JG: Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol (1985) 91: 1487-1500, 2001.
8. Spindler V, Peter D, Harms GS, Asan E and Waschke J: Ultrastructural analysis reveals cAMP-dependent enhancement of microvascular endothelial barrier functions via Rac1-mediated reorganization of intercellular junctions. Am J Pathol 178: 2424-2436, 2011.
9. Peng H, Wang C, Ye ZC, et al: How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation. Acta Diabetol 47 (Suppl 1): 57-63, 2010.
10. Spindler V, Schlegel N and Waschke J: Role of GTPases in control of microvascular permeability. Cardiovasc Res 87: 243-253, 2010.
11. Semina EV, Rubina KA, Rutkevich PN, Voyno-Yasenetskaya TA, Parfyonova YV and Tkachuk VA: T-cadherin activates Rac1 and Cdc42 and changes endothelial permeability. Biochemistry (Mosc) 74: 362-370, 2009.
12. Mehta D and Malik AB: Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367, 2006.
13. Guo X, Wang L, Chen B, et al: ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 297: H238-H246, 2009.
14. Guo XH, Huang QB, Chen B, et al: Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells. APMIS 114: 874-883, 2006.
15. Guo XH, Huang QB, Chen B, Wang SY, Hou FF and Fu N: Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells. Sheng Li Xue Bao 57: 205-210, 2005 (In Chinese).
16. Sheikpranbabu S, Haribalaganesh R, Lee KJ and Gurunathan S: Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie 92: 1040-1051, 2010.
17. Akis N and Madaio MP: Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int 65: 2223-2227, 2004.
18. Rops AL, van der Vlag J, Jacobs CW, et al: Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines. Kidney Int 66: 2193-2201, 2004.
19. Laulajainen T, Julkunen I, Haltia A, Knuutila S, Miettinen A and Holthöfer H: Establishment and characterization of a rat glomerular endothelial cell line. Lab Invest 69: 183-192, 1993.
20. Glomb MA and Monnier VM: Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10017-10026, 1995.
21. Nagai R, Unno Y, Hayashi MC, Masuda S, Hayase F, Kinae N and Horiuchi S: Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 51: 2833-2839, 2002.
22. Hou FF, Boyce J, Chertow GM, Kay J and Owen WF Jr: Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol 9: 277-283, 1998.
23. Hou FF, Miyata T, Boyce J, et al: beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 59: 990-1002, 2001.
24. Eiselein L, Wilson DW, Lamé MW and Rutledge JC: Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol 292: H2745-H2753, 2007.
25. Zheng HZ, Zhao KS, Zhou BY and Huang QB: Role of Rho kinase and actin filament in the increased vascular permeability of skin venules in rats after scalding. Burns 29: 820-827, 2003.
26. Wu H and Parsons JT: Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120: 1417-1426, 1993.
27. Paradis H, Islam T, Tucker S, Tao L, Koubi S and Gendron RL: Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin. J Cell Sci 121: 1965-1972, 2008.
28. Ando K, Ishibashi T, Ohkawara H, et al: Crucial role of membrane type 1 matrix metalloproteinase (MT1-MMP) in RhoA/Rac1-dependent signaling pathways in thrombin stimulated endothelial cells. J Atheroscler Thromb 18: 762-773, 2011.
29. Boutoille D, Marechal X, Pichenot M, Chemani C, Guery B and Faure K: FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin. Exp Lung Res 35: 263-271, 2009.
30. Kajiya M, Komatsuzawa H, Papantonakis A, et al: Aggregatibacter actinomycetemcomitans Omp29 is associated with bacterial entry to gingival epithelial cells by F-actin rearrangement. PLoS One 6: e18287, 2011.
31. Swärd P and Rippe B: Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Acta Physiol (Oxf) 204: 294-307, 2012.
32. Balakumar P, Chakkarwar VA, Krishan P and Singh M: Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? Biomed Pharmacother 63: 171-179, 2009.
33. Thomas MC: Pathogenesis and progression of proteinuria. Contrib Nephrol 170: 48-56, 2011.
34. Dane MJ, van den Berg BM, Avramut MC, et al: Glomerular endothelial surface layer acts as a barrier against albumin filtration. Am J Pathol 82: 1532-1540, 2013.
35. Stewart RJ and Marsden PA: Vascular endothelial cell activation in models of vascular and glomerular injury. Kidney Int Suppl 45: S37-S44, 1994.
36. Koike K, Aiboshi J, Shinozawa Y, Sekine K, Endo T and Yamamoto Y: Correlation of glomerular permeability, endothelial injury, and postoperative multiple organ dysfunction. Surg Today 34: 811-816, 2004.
37. Bates DO: Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87: 262-271, 2010.
38. Bogatcheva NV and Verin AD: The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76: 202-207, 2008.
39. Soulis T, Thallas V, Youssef S, et al: Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40: 619-628, 1997.
40. Hori O, Yan SD, Ogawa S, Kuwabara K, Matsumoto M, Stern D and Schmidt AM: The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrol Dial Transplant 11 (Suppl 5): 13-16, 1996.
41. Yamagishi S: Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 46: 217-224, 2011.
42. Bond M, Wu YJ, Sala-Newby GB and Newby AC: Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo. Cardiovasc Res 80: 290-298, 2008.
43. Szczepanowska J: Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements. Acta Biochim Pol 56: 225-234, 2009.
44. Pai SY, Kim C and Williams DA: Rac GTPases in human diseases. Dis Markers 29: 177-187, 2010.
45. Williams LM, Lali F, Willetts K, et al: Rac mediates TNF-induced cytokine production via modulation of NF-kappaB. Mol Immunol 45: 2446-2454, 2008.
46. Mondal S, Ghosh-Roy S, Loison F, et al: PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase. J Immunol 187: 5783-5794, 2011.
47. Chang F, Lemmon C, Lietha D, Eck M and Romer L: Tyrosine phosphorylation of Rac1: a role in regulation of cell spreading. PLoS One 6: e28587, 2011.
48. Jacobson JR, Dudek SM, Singleton PA, Kolosova IA, Verin AD and Garcia JG: Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am J Physiol Lung Cell Mol Physiol 291: L289-L295, 2006.
49. Weed SA, Du Y and Parsons JT: Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1. J Cell Sci 111: 2433-2443, 1998.
50. Adamson RH, Sarai RK, Altangerel A, Thirkill TL, Clark JF and Curry FR: Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. Cardiovasc Res 88: 344-351, 2010.
51. Maharjan S, Kim K, Agrawal V, et al: Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway. Biochem Biophys Res Commun 435: 420-427, 2013.